Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone)
Brand Names: Melox
Methodology & AI Transparency ⓘ
Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) represents a over-the-counter branded calculi dissolution agent entry registered by Belmora LLC with package codes 27854-117, 27854-115.
- 2 Real-world patient consensus: Branded calculi dissolution agent presentation of Aluminum Hydroxide, Magnesium Hydroxide, Simethicone (Belmora LLC); generic reference RxCUI 307746.
- 3 Typical cash cost range: 30-day cash pricing ranges from $9.44 discount cash to $34.50 walk-in retail (NADAC $0.0131/unit).
- 4 Top reported side effects / signs: Leading openFDA/SPL adverse events for Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone): dyspepsia (6.1%), nausea (9.3%), headache (8.6%).
Ask our AI Specialists anything about Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone)
Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) Mechanism, CYP450 Pathways & DailyMed Monograph
Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) represents a over-the-counter branded calculi dissolution agent entry registered by Belmora LLC with package codes 27854-117, 27854-115. Reviewed against 2024-10-04 FDA SPL standards (400 mg/10mL / 400 mg/10mL Liquid; 200 mg/5mL / 200 mg/5mL Suspension), clinical deployment addresses Uses relieves: ; acid indigestion ; heartburn ; sour stomach ; upset stomach and gas associated with these symptoms
Melox achieves therapeutic action via Aluminum Hydroxide, Magnesium Hydroxide, Simethicone, engaging calculi dissolution agent physiological pathways with class-characteristic hepatorenal disposition. Manufactured in 400 mg/10mL / 400 mg/10mL Liquid; 200 mg/5mL / 200 mg/5mL Suspension (registered by Belmora LLC, NDC 27854-117, 27854-115), pharmacists evaluate FDA Orange Book therapeutic equivalence when comparing branded Melox ($34.50 retail) with generic Aluminum Hydroxide, Magnesium Hydroxide, Simethicone ($9.44 low cash).
With Steady-state plasma equilibrium reached over 6–14 hour t½ intervals for Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) residence kinetics and Approximately 59% to 71% enteral uptake across labeled Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) strengths bioavailability, Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) undergoes predominantly hepatic biotransformation with renal elimination of polar melox (aluminum hydroxide, magnesium hydroxide, simethicone) conjugates and establishes therapeutic activity over maximum serum exposure occurs 2–5 hours after melox (aluminum hydroxide, magnesium hydroxide, simethicone) dosing.
Standard adult regimens span 400 mg/10mL / 400 mg/10mL Liquid, 200 mg/5mL / 200 mg/5mL Suspension. Prescribers screen specifically against contraindicated in patients with prior serious allergic response to melox (aluminum hydroxide, magnesium hydroxide, simethicone) (ndc 27854-117); severe baseline organ impairment where aluminum hydroxide, magnesium hydroxide, simethicone accumulation exceeds safe therapeutic margins, while community micro-logs most frequently note nausea (9.3% of reports), headache (8.6% of reports), dyspepsia (6.1% of reports).
Reconcile eGFR-adjusted medications before escalating Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) in polypharmacy regimens.
Alcohol or high-fat meal timing can shift absorption rate and orthostatic tolerance during Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) dosing.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Contraindicated in patients with prior serious allergic response to Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) (NDC 27854-117)
- Severe baseline organ impairment where Aluminum Hydroxide, Magnesium Hydroxide, Simethicone accumulation exceeds safe therapeutic margins
Logged Side-Effect Incidence (15 Reports)
Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine: What a 4,050-Participant Study Found IndoVac in adults showed favourable safety profile and elicited non-inferior immune response to Covovax. Vaccine • 2024-04-30 • Phase III Randomized Trial | N = 4,050 | 90/100 | PMID 38575433 ↗ |
| Can This Approach Help? Inside the Latest Research on Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion Especially on day 120, PD-1 was upregulated on CD4 + T EMRA and T CM , and on CD8 + T EM and T CM cells; accordingly, proliferation and IFN-γ secretion capacities tended to decline after 4 months. Scientific reports • 2023-03-21 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 36944716 ↗ |
| Can This Approach Help? Inside the Latest Research on Immunogenicity and safety of a bivalent, adjuvant system 04-adjuvanted human The result analysis of this study supports the noninferiority of Papilloguard (Noyan Pajouhan Biopharma) to Cervarix (GlaxoSmithKline) in terms of safety and immunogenicity based on the GMT ratio. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) • 2022-11-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 35352698 ↗ |
| New Insights on Intravenous Meloxicam Versus Ketorolac for Pain Control Following Total Joint: What a 223-Participant Study Found The use of IV meloxicam as part of a perioperative pain management protocol led to increased opioid consumption, longer lengths of stay, and a lower rate of same-day discharges than IV ketorolac. The Journal of arthroplasty • 2026-07-15 • Phase III Randomized Trial | N = 223 | 88/100 | PMID 41167538 ↗ |
| Can This Approach Help? Inside the Latest Research on Economic Impact of Preoperative Meloxicam IV Administration in Total Knee Patients in the meloxicam IV 30 mg vs placebo group (n = 93 vs 88) incurred an adjusted $2,266 (95% CI: -$1,035, $5,116; p = 0.1689) lower total hospital costs and an adjusted 8.6% (95% confidence interval [CI]: -2.0%, 18.1%;... Journal of pain & palliative care pharmacotherapy • 2021-09-15 • Phase III Randomized Trial | N = 93 | 88/100 | PMID 34280067 ↗ |
Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0131/unit (~$0.39/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 15 Anonymous DotMD Community Micro-Logs | $9.44 / mo | View logs ↓ |
Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) RxNorm Concept ID | 307746 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0131 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $9.44 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 74.00% Worth It (15 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) Patient Community, Cohort Filters & Dosage Logs
Federal clinical ledger for Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) integrating DailyMed SPL (2024-10-04), CMS NADAC ($0.0131/unit), and 15 Zero-PHI patient logs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Melox (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) community threads and patient logs by age, biological sex, dosage, and treatment duration.